A systematic literature review comparing methods for the measurement of patient persistence and adherence-Reference-Cited by-同舟云学术

A systematic literature review comparing methods for the measurement of patient persistence and adherence

Published:2018-06-04 Issue:9 Volume:34 Page:1613-1625
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Forbes Carol A.¹,Deshpande Sohan¹,Sorio-Vilela Francesc²,Kutikova Lucie²,Duffy Steven¹,Gouni-Berthold Ioanna³,Hagström Emil⁴

Affiliation:

1. Kleijnen Systematic Reviews Ltd, York, UK;

2. Global Health Economics, Amgen (Europe) GmbH, Zug, Switzerland;

3. Polyclinic for Endocrinology, Diabetes and Preventive Medicine, University of Cologne, Cologne, Germany;

4. Uppsala Clinical Research Center (UCR), Department of Medical Sciences, University of Uppsala, Uppsala, Sweden

Funder

Amgen Europe GmbH

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/03007995.2018.1477747

Reference56 articles.

1. A systematic review to assess adherence and persistence with statins

2. Medication Adherence: WHO Cares?

3. Polypill treatments for cardiovascular diseases

4. Heads of Medicines Agencies, European Medicines Agency. Guideline on good pharmacovigilance practices (GVP). Module VI – management and reporting of adverse reactions to medicinal products (Rev 1). EMA/873138/2011 Rev 1*. London: European Medicines Agency, 2014. Available at: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2014/09/WC500172402.pdf [Last accessed 7 February 2017]

Cited by 94 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Translation, transcultural adaptation, and validation of the Brazilian Portuguese version of the general medication adherence scale (GMAS) in patients with high blood pressure;Exploratory Research in Clinical and Social Pharmacy;2024-12

2. Overall Medication Adherence as an Indicator for Health Outcomes Among Elderly Patients With Hypertension and Diabetes;The American Journal of Medicine;2024-08

3. Adherence and persistence among people with type 2 diabetes newly initiating oral semaglutide versus DPP-4is in a US real-world setting;Primary Care Diabetes;2024-07

4. Characterizing the treatment patterns, medication burden, and patient demographics of older adults with major depressive disorder treated with antidepressants with or without selected comorbidities;Current Medical Research and Opinion;2024-05-16

5. Liraglutide 3.0 mg once daily for the treatment of overweight and obesity in patients hospitalised at a forensic psychiatric department: A 26‐week open‐label feasibility study;Acta Psychiatrica Scandinavica;2024-04-17